A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD
Publication
, Conference
Parikh, S; Brochstein, JA; Wease, S; Martin, PL; Horwitz, ME; Schwarzbach, A; Kurtzberg, J
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
March 1, 2018
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2018
Volume
24
Issue
3
Start / End Page
S157 / S158
Location
Salt Lake City, UT
Publisher
ELSEVIER SCIENCE INC
Conference Name
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT)
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Parikh, S., Brochstein, J. A., Wease, S., Martin, P. L., Horwitz, M. E., Schwarzbach, A., & Kurtzberg, J. (2018). A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 24, pp. S157–S158). Salt Lake City, UT: ELSEVIER SCIENCE INC.
Parikh, Suhag, Joel A. Brochstein, Stephen Wease, Paul L. Martin, Mitchell E. Horwitz, Aurelie Schwarzbach, and Joanne Kurtzberg. “A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24:S157–58. ELSEVIER SCIENCE INC, 2018.
Parikh S, Brochstein JA, Wease S, Martin PL, Horwitz ME, Schwarzbach A, et al. A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2018. p. S157–8.
Parikh, Suhag, et al. “A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 24, no. 3, ELSEVIER SCIENCE INC, 2018, pp. S157–58.
Parikh S, Brochstein JA, Wease S, Martin PL, Horwitz ME, Schwarzbach A, Kurtzberg J. A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2018. p. S157–S158.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2018
Volume
24
Issue
3
Start / End Page
S157 / S158
Location
Salt Lake City, UT
Publisher
ELSEVIER SCIENCE INC
Conference Name
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT)
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences